2166-A DISEASE PROGRESSION IN TAIWANESE NON-ALCOHOLIC STEATOHEPATITIS PATIENTS: SUBGROUP ANALYSIS OF THE PLACEBO PATIENTS IN A DOUBLE-BLIND RANDOMIZED TRIAL Ming-Lun Yeh 1,2 , Jee-Fu Huang 3 , Chung-Feng Huang 4 , Chia-Yen Dai 4 , Ming-Lung Yu 5 and Wan Long Chuang 6 , (1)Kaohsiung Medical University, Kaohsiung, Taiwan, (2)Kaohsiung Medical University, (3)Kaohsiung Medical University Hospital, (4)Hepatobiliary Section, Department of Internal Medicine, and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, (5)Kaohsiung Chang Gung Memorial Hospital, (6)Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University Background: Disease progression remains elusive in Asian non-alcoholic steatohepatitis (NASH) patients

This is the reality for millions living with Long COVID symptoms, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and complex chronic conditions like dysautonomia and mast cell activation syndrome (MCAS)
These microorganisms produce exopolysaccharides that boost drought resistance
Sn phm l tinh ty c cht lc t cng ngh Nht Bn v chui thnh phn c nghin cu v kim nghim kht khe v an ton v hiu qu khi s dng
And the effect of stress on our cells is oxidative stress